Estrogen and cancer.

  title={Estrogen and cancer.},
  author={Jing Liang and Yongfeng Shang},
  journal={Annual review of physiology},
Estrogen exhibits a broad spectrum of physiological functions ranging from regulation of the menstrual cycle and reproduction to modulation of bone density, brain function, and cholesterol mobilization. Despite the beneficial actions of endogenous estrogen, sustained exposure to exogenous estrogen is a well-established risk factor for various cancers. We summarize our current understanding of the molecular mechanisms of estrogen signaling in normal and cancer cells and discuss the major… 

Figures from this paper

Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer

Understanding of molecular mechanisms of estrogen signaling pathways in thyroid cancer will provide a new target for the treatment of thyroid carcinoma by blocking estrogen and its related action pathway.

GPER Mediates Non-Genomic Effects of Estrogen.

This chapter presents some of the different experimental techniques currently used to demonstrate the functional role of GPER in mediating non-genomic actions of estrogens, such as the dual luciferase assay, assessment of the involvement of GP ER in the stimulation of cell migration in breast cancer cell lines and in cancer-associated fibroblasts, and chromatin immunoprecipitation assay.


This review focused on the literature survey on Selective estrogen receptor modulators (SERMs) in prostate carcinogenesis and prevention because SERMs have shown the ability to prevent and treat prostate cancer.

Role of estrogen and its receptors mediated-autophagy in cell fate and human diseases

  • Yong WeiJian Huang
  • Biology, Medicine
    The Journal of Steroid Biochemistry and Molecular Biology
  • 2019

Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen Signaling Pathway

The potential targets of treatment strategies based on the estrogen signaling pathway in the treatment of liver cancer and the principal obstacles currently encountered for future investigation are highlighted.

Estrogen signaling as a bridge between the nucleus and mitochondria in cardiovascular diseases

The common pathways and mechanisms by which estrogens modulate the retrograde and anterograde communication between the nucleus and mitochondria are described, highlighting the role of genomic and non-genomic pathways mediated by estrogen receptors.

The Emerging Role of Estrogens in Thyroid Redox Homeostasis and Carcinogenesis

It is demonstrated that the thyroid gland of adult female rats exhibits higher hydrogen peroxide production and lower enzymatic antioxidant defense in comparison with male glands, suggesting the possible involvement of thyroid redox homeostasis and estrogen in the development of thyroid carcinogenesis.

Beyond the Antioxidant Activity of Dietary Polyphenols in Cancer: the Modulation of Estrogen Receptors (ERs) Signaling

The role and effects of food-contained polyphenols in hormone-related cancers will be reviewed, mainly focusing on the differentpolyphenols’ mechanisms of action with particular attention on their estrogen receptor-based effects, and on the consequences of such processes on tumor progression and development.



Vascular Actions of Estrogens: Functional Implications

Key aspects of the relevant pathophysiology of inflammation, atherosclerosis, stroke, migraine, and thrombosis are reviewed concerning current knowledge of estrogenic effects, and consensus opinions are emphasized.

Estrogens, regulation of p53 and breast cancer risk: a balancing act

Transcriptional profiles now suggest that ovarian hormones stimulate a constellation of genes that interact with NF-κB and p53 to arbitrate the competing demands for proliferation and surveillance, and render the breast epithelium resistant to tumors.

Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

Breast cancer cells can be sensitized to estrogen-induced apoptosis through suppression of glutathione by BSO (L-buthionine sulfoximine).

Estrogen receptors: how do they signal and what are their targets.

This review focuses on several of the interesting recent discoveries concerning estrogen receptors, on estrogen as a morphogen, and on the molecular mechanisms of anti-estrogen signaling.

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis

  • Y. Shang
  • Medicine, Biology
    Nature Reviews Cancer
  • 2006
Oestrogen and SERMs are thought to be involved in endometrial carcinogenesis through their effects on transcriptional regulation, and affect the transduction of cellular signalling pathways that govern cell growth and proliferation, through downstream effectors such as PAX2.

Minireview: Obesity and breast cancer: the estrogen connection.

An overview of estrogen's relationship with both obesity and breast cancer as separate entities is provided and other growth factors that may be involved in this relationship are considered.

Cracking the estrogen receptor's posttranslational code in breast tumors.

A thorough understanding of the complete picture of these modifications in ER carcinogenesis might not only open new avenues for identifying new markers for prognosis or prediction of response to endocrine therapy but also could promote the development of novel therapeutic strategies.

The different roles of ER subtypes in cancer biology and therapy

The changes in the bioavailability of ERs in tumours promote the selective restoration of their activity as one of the major therapeutic approaches for hormone-dependent cancers.

Molecular Determinants for the Tissue Specificity of SERMs

It is shown that both tamoxifen and raloxifene induce the recruitment of corepressors to target gene promoters in mammary cells, which determines the cellular response to selective estrogen receptor modulators.